The COVID-19 pandemic has presented unprecedented challenges and unexpected opportunities for small medical technology companies and start-ups. Join Ashley for a discussion of the current state of the U.S. medtech environment and the potential impact of the pandemic on the industry.
Also, An update on the upcoming 2020 Virtual MedTech conference and new date for the Toronto MedTech Conference in 2022
- How is capital formation being affected by COVID-19
- How are companies expanding their networks during this unprecedented time
- What tax policies are needed to help companies survive the pandemic
- Update: MedTech 2020 Virtual Conference (originally scheduled for Toronto)
Date: Friday, July 24, 2020
Time: 11:00 am - 12:00 pm PDT (Pacific Time)
Join Info: Dial-in & Web Access Information Provided with Registration Confirmation Email
Executive Director, AdvaMed Accel & Global Head - Investor Relations, AdvaMed
Ashley Wittorf is the Executive Director of AdvaMed Accel, the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medtech manufacturers. In this role, she focuses on facilitating a policy environment conducive to capital formation and innovation, advocating for payment and regulatory policies that are favorable to emerging companies, and providing educational opportunities for industry leaders in this entrepreneurial sector. Ms. Wittorf also oversees all relationships with the investment community at AdvaMed and is responsible for improving representation of the broader innovation ecosystem in the association’s advocacy work. Prior to joining AdvaMed in 2012, Ms. Wittorf spent nearly ten years working in the medtech and pharmaceutical industries with a focus on product development, commercialization strategy, and operations – working with both small, venture-backed enterprises and large corporations. As a recognized thought leader in medtech innovation, Ms. Wittorf has served in several advisory capacities, including on the board of MedTech Innovator and through government-related initiatives. These include the FDA CDRH Entrepreneurs-in-Residence Program and the NIH HEAL Partnership Committee. Ms. Wittorf received a master’s degree in bioengineering and a bachelor’s degree in mechanical engineering from the Georgia Institute of Technology, and a Master of Business Administration from the University of Virginia’s Darden School of Business.